Clinical pitfalls and serological diagnostics of MuSK myasthenia gravis.
Journal article
Kwon YN. et al, (2022), J Neurol
Frequency of MOG-IgG in cerebrospinal fluid versus serum
Journal article
Pace S. et al, (2021), Journal of Neurology, Neurosurgery and Psychiatry
Clinical features which predict neuronal surface autoantibodies in new-onset focal epilepsy: implications for immunotherapies
Journal article
McGinty RN. et al, (2021), Journal of Neurology, Neurosurgery & Psychiatry, 92, 291 - 294
Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Positive Patients in a Multi-Ethnic Canadian Cohort
Journal article
Cross H. et al, (2021), Frontiers in Neurology, 11
Stop testing for autoantibodies to the VGKC-complex: only request LGI1 and CASPR2
Journal article
Michael S. et al, (2020), Practical Neurology, 20, 377 - 384
Prevalence of NMOSD and MS in the Indigenous Populations of Australia and New Zealand
Conference paper
Broadley SA. et al, (2020), MULTIPLE SCLEROSIS JOURNAL, 26, NP44 - NP44
Serum Cytokine Profiles of Myelin Oligodendrocyte Glycoprotein Encephalomyelitis
Conference paper
Kwon YN. et al, (2020), MULTIPLE SCLEROSIS JOURNAL, 26, NP88 - NP88
Cell-based assays for the detection of MOG antibodies: a comparative study.
Journal article
Gastaldi M. et al, (2020), J Neurol
Prevalence and incidence of neuromyelitis optica spectrum disorder, aquaporin-4 antibody-positive NMOSD and MOG antibody-positive disease in Oxfordshire, UK.
Journal article
O'Connell K. et al, (2020), J Neurol Neurosurg Psychiatry
Distinctive binding properties of human monoclonal LGI1 autoantibodies determine pathogenic mechanisms
Journal article
Ramberger M. et al, (2020), Brain, 143, 1731 - 1745
Cell-based assays for the detection of myelin oligodendrocyte glycoprotein antibodies: a single centre comparative study
Conference paper
Gastaldi M. et al, (2020), EUROPEAN JOURNAL OF NEUROLOGY, 27, 74 - 74
Development Of Silent Brain Lesions In Pediatric Patients With Antibodies To Myelin Oligodendrocyte Glycoprotein
Conference paper
Fadda G. et al, (2020), MULTIPLE SCLEROSIS JOURNAL, 26, 30 - 30
Immunological mechanisms for the efficacy of Rituximab in aquaporin-4 autoantibody mediated Neuromyelitis Optica spectrum disorders
Conference paper
Damato V. et al, (2020), EUROPEAN JOURNAL OF NEUROLOGY, 27, 74 - 74
International multicenter examination of MOG antibody assays (vol 7, e674, 2020)
Journal article
Reindl M. et al, (2020), NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 7
Real-world prevalence of autoantibodies in epilepsy
Conference paper
McGinty RN. et al, (2020), EUROPEAN JOURNAL OF NEUROLOGY, 27, 61 - 61
Refining cell-based assay to detect MOG-IgG in patients with central nervous system inflammatory diseases
Journal article
Kim Y. et al, (2020), Multiple Sclerosis and Related Disorders, 40, 101939 - 101939
The clinical profile of NMOSD in Australia and New Zealand.
Journal article
Bukhari W. et al, (2020), J Neurol, 267, 1431 - 1443
Bone health in neuromyelitis optica: Bone mineral density and fractures.
Journal article
Kwon YN. et al, (2020), Mult Scler Relat Disord, 42
Development of Silent Brain Lesions in Pediatric Patients with anti-MOG-Associated Demyelination
Conference paper
Fadda G. et al, (2020), NEUROLOGY, 94